Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU International flag

Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5 - Downloaded Version null See the Directory of published versions

ValueSet: R2V20227ForR5

Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R2-v2-0227-for-R5 Version: 0.1.0
Standards status: Trial-use Maturity Level: 0 Computable Name: R2V20227ForR5

This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/v2-0227|2.8.2 for use in FHIR R5.

This value set is part of the cross-version definitions generated to enable use of the value set http://hl7.org/fhir/ValueSet/v2-0227|2.8.2 as defined in FHIR DSTU2 in FHIR R5.

The source value set is bound to the following FHIR DSTU2 elements:

Note that all concepts are included in this cross-version definition because no concepts have compatible representations

Following are the generation technical comments:

FHIR ValueSet http://hl7.org/fhir/ValueSet/v2-0227|2.8.2, defined in FHIR DSTU2 does not have any mapping to FHIR R5

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/v2/0227 version 📍1.0.2
    CodeDisplay
    ABAbbott Laboratories
    ADAdams Laboratories, Inc.
    ALPAlpha Therapeutic Corporation
    ARArmour
    AVBAventis Behring L.L.C.
    AVIAviron
    BABaxter Healthcare Corporation
    BAHBaxter Healthcare Corporation
    BAYBayer Corporation
    BPBerna Products
    BPCBerna Products Corporation
    CENCenteon L.L.C.
    CHIChiron Corporation
    CMPCelltech Medeva Pharmaceuticals
    CNJCangene Corporation
    CONConnaught
    DVCDynPort Vaccine Company, LLC
    EVNEvans Medical Limited
    GEOGeoVax Labs, Inc.
    GREGreer Laboratories, Inc.
    IAGImmuno International AG
    IMMerieux
    IUSImmuno-U.S., Inc.
    JPNThe Research Foundation for Microbial Diseases of Osaka University
    KGCKorea Green Cross Corporation
    LEDLederle
    MAMassachusetts Public Health Biologic Laboratories
    MBLMassachusetts Biologic Laboratories
    MEDMedImmune, Inc.
    MILMiles
    MIPBioport Corporation
    MSDMerck & Co., Inc.
    NABNABI
    NAVNorth American Vaccine, Inc.
    NOVNovartis Pharmaceutical Corporation
    NVXNovavax, Inc.
    NYBNew York Blood Center
    ORTOrtho-Clinical Diagnostics
    OTCOrganon Teknika Corporation
    OTHOther manufacturer
    PDParkedale Pharmaceuticals
    PMCsanofi pasteur
    PRXPraxis Biologics
    PWJPowderJect Pharmaceuticals
    SCLSclavo, Inc.
    SISwiss Serum and Vaccine Inst.
    SKBGlaxoSmithKline
    SOLSolvay Pharmaceuticals
    TALTalecris Biotherapeutics
    UNKUnknown manufacturer
    USAUnited States Army Medical Research and Material Command
    VXGVaxGen
    WAWyeth-Ayerst
    WALWyeth-Ayerst
    ZLBZLB Behring

 

Expansion

This value set expansion contains 55 concepts.

SystemVersionCodeDisplayJSONXML
http://hl7.org/fhir/v2/02271.0.2  ABAbbott Laboratories
http://hl7.org/fhir/v2/02271.0.2  ADAdams Laboratories, Inc.
http://hl7.org/fhir/v2/02271.0.2  ALPAlpha Therapeutic Corporation
http://hl7.org/fhir/v2/02271.0.2  ARArmour
http://hl7.org/fhir/v2/02271.0.2  AVBAventis Behring L.L.C.
http://hl7.org/fhir/v2/02271.0.2  AVIAviron
http://hl7.org/fhir/v2/02271.0.2  BABaxter Healthcare Corporation
http://hl7.org/fhir/v2/02271.0.2  BAHBaxter Healthcare Corporation
http://hl7.org/fhir/v2/02271.0.2  BAYBayer Corporation
http://hl7.org/fhir/v2/02271.0.2  BPBerna Products
http://hl7.org/fhir/v2/02271.0.2  BPCBerna Products Corporation
http://hl7.org/fhir/v2/02271.0.2  CENCenteon L.L.C.
http://hl7.org/fhir/v2/02271.0.2  CHIChiron Corporation
http://hl7.org/fhir/v2/02271.0.2  CMPCelltech Medeva Pharmaceuticals
http://hl7.org/fhir/v2/02271.0.2  CNJCangene Corporation
http://hl7.org/fhir/v2/02271.0.2  CONConnaught
http://hl7.org/fhir/v2/02271.0.2  DVCDynPort Vaccine Company, LLC
http://hl7.org/fhir/v2/02271.0.2  EVNEvans Medical Limited
http://hl7.org/fhir/v2/02271.0.2  GEOGeoVax Labs, Inc.
http://hl7.org/fhir/v2/02271.0.2  GREGreer Laboratories, Inc.
http://hl7.org/fhir/v2/02271.0.2  IAGImmuno International AG
http://hl7.org/fhir/v2/02271.0.2  IMMerieux
http://hl7.org/fhir/v2/02271.0.2  IUSImmuno-U.S., Inc.
http://hl7.org/fhir/v2/02271.0.2  JPNThe Research Foundation for Microbial Diseases of Osaka University
http://hl7.org/fhir/v2/02271.0.2  KGCKorea Green Cross Corporation
http://hl7.org/fhir/v2/02271.0.2  LEDLederle
http://hl7.org/fhir/v2/02271.0.2  MAMassachusetts Public Health Biologic Laboratories
http://hl7.org/fhir/v2/02271.0.2  MBLMassachusetts Biologic Laboratories
http://hl7.org/fhir/v2/02271.0.2  MEDMedImmune, Inc.
http://hl7.org/fhir/v2/02271.0.2  MILMiles
http://hl7.org/fhir/v2/02271.0.2  MIPBioport Corporation
http://hl7.org/fhir/v2/02271.0.2  MSDMerck & Co., Inc.
http://hl7.org/fhir/v2/02271.0.2  NABNABI
http://hl7.org/fhir/v2/02271.0.2  NAVNorth American Vaccine, Inc.
http://hl7.org/fhir/v2/02271.0.2  NOVNovartis Pharmaceutical Corporation
http://hl7.org/fhir/v2/02271.0.2  NVXNovavax, Inc.
http://hl7.org/fhir/v2/02271.0.2  NYBNew York Blood Center
http://hl7.org/fhir/v2/02271.0.2  ORTOrtho-Clinical Diagnostics
http://hl7.org/fhir/v2/02271.0.2  OTCOrganon Teknika Corporation
http://hl7.org/fhir/v2/02271.0.2  OTHOther manufacturer
http://hl7.org/fhir/v2/02271.0.2  PDParkedale Pharmaceuticals
http://hl7.org/fhir/v2/02271.0.2  PMCsanofi pasteur
http://hl7.org/fhir/v2/02271.0.2  PRXPraxis Biologics
http://hl7.org/fhir/v2/02271.0.2  PWJPowderJect Pharmaceuticals
http://hl7.org/fhir/v2/02271.0.2  SCLSclavo, Inc.
http://hl7.org/fhir/v2/02271.0.2  SISwiss Serum and Vaccine Inst.
http://hl7.org/fhir/v2/02271.0.2  SKBGlaxoSmithKline
http://hl7.org/fhir/v2/02271.0.2  SOLSolvay Pharmaceuticals
http://hl7.org/fhir/v2/02271.0.2  TALTalecris Biotherapeutics
http://hl7.org/fhir/v2/02271.0.2  UNKUnknown manufacturer
http://hl7.org/fhir/v2/02271.0.2  USAUnited States Army Medical Research and Material Command
http://hl7.org/fhir/v2/02271.0.2  VXGVaxGen
http://hl7.org/fhir/v2/02271.0.2  WAWyeth-Ayerst
http://hl7.org/fhir/v2/02271.0.2  WALWyeth-Ayerst
http://hl7.org/fhir/v2/02271.0.2  ZLBZLB Behring

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code